Windtree Therapeutics Stock (NASDAQ: WINT) stock price, news, charts, stock research, profile.
You can purchase shares of Windtree Therapeutics (NASDAQ:WINT) through any online brokerage.
Other companies in Windtree Therapeutics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Barinthus Biotherapeutics (NASDAQ:BRNS), OS Therapies (AMEX:OSTX) and CollPlant Biotechnologies (NASDAQ:CLGN).
Windtree Therapeutics has a consensus price target of $7.00.
The stock price for Windtree Therapeutics (NASDAQ: WINT) is $0.0969 last updated February 20, 2025 at 7:49 PM EST.
There are no upcoming dividends for Windtree Therapeutics.
Windtree Therapeutics’s Q4 earnings are confirmed for Tuesday, April 15, 2025.
There is no upcoming split for Windtree Therapeutics.
Windtree Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.